Compared to Estimates, Cognizant (CTSH) Q4 Earnings: A Look at Key Metrics

For the quarter ended December 2024, Cognizant (CTSH) reported revenue of $5.08 billion, up 6.8% over the same period last year. EPS came in at $1.21, compared to $1.18 in the year-ago quarter.The reported revenue represents a surprise of +0.49% over the Zacks Consensus Estimate of $5.06 billion. With the consensus EPS estimate being $1.12, the EPS surprise was +8.04%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Cognizant performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenue- Products and Resources: $1.30 billion versus $1.28 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +11.4% change. Revenue- Health Sciences: $1.54 billion versus the two-analyst average estimate of $1.50 billion. The reported number represents a year-over-year change of +10.4%. Revenue- Financial services: $1.44 billion compared to the $1.49 billion average estimate based on two analysts. The reported number represents a change of +2.9% year over year. Revenue- Communications, Media and Technology: $811 million versus $803.52 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +0.9% change. View all Key Company Metrics for Cognizant here>>>Shares of Cognizant have returned +10.5% over the past month versus the Zacks S&P 500 composite's +1.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cognizant Technology Solutions Corporation (CTSH): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks